DJIA 17,745.98 0.00 0.00%
NASDAQ 5,128.79 0.00 0.00%
S&P 500 2,111.57 2.94 0.14%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

47.31 -0.03 (-0.06%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $47.31 -0.06%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.25
Previous Close $47.34
Daily Range $46.26 - $48.00
52-Week Range $30.05 - $52.33
Market Cap $5.9B
P/E Ratio -71.97
Dividend (Yield) $0.00 (0.0%)
Volume 820,030
Average Daily Volume 886,812
Current FY EPS -$0.80

Sector

Healthcare

Industry

Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

Still Profitless in Seattle Genetics

But a growth opportunity is around the corner.

Seattle Genetics (SGEN) Clay B. Siegall on Q2 2015 Results - Earnings Call Transcript

Seattle Genetics (SGEN) Q2 2015 Results - Earnings Call Webcast

First Week of SGEN March 2016 Options Trading

How To Make Money In Small To Nano-Cap Biotech

Interesting SGEN Put And Call Options For August 21st

Seattle Genetics' Collaborative Approach To Fighting Cancer Makes It A Buy

Seattle Genetics Announces Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations at the Intern

Seattle Genetics Announces Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations at the International Conference on Malignant Lymphoma

The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutic

The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutics - Press Releases

Seattle Genetics-Unum Therapeutics Tie Up for Cancer Drugs - Analyst Blog

See More SGEN News...

SGEN's Top Competitors

SGEN $47.31 (-0.06%)
Current stock: SGEN
AMGN $180.55 (5.16%)
Current stock: AMGN
GILD $118.05 (0.13%)
Current stock: GILD
BIIB $316.19 (-0.26%)
Current stock: BIIB